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INTRODUCTION 
Acetaminophen (p-hydroxy acetanilide) is a widely used analgesic 
and antipyretic drug. It is an ingredient in over 200 medicinal 
formulations. At therapeutic doses, it is relatively safe and has none 
of the adverse effects of aspirin (Ameer and Greenblatt, 1977; Hinson, 
1980). 
Overdoses of acetaminophen, however, may produce a fulminating 
hepatic necrosis in both humans and animals (Hinson et al., 1981; 
Jackson et al., 1984). This necrosis occurs mainly in the centrilobular 
region of the liver. 
The hepatotoxicity produced after overdose is not due to 
acetaminophen itself, but is due to an electrophilic metabolite formed 
by the cytochrome P-450 mixed function oxidase system. This metabolite 
is currently thought to be an imidoquinone (Black, 1980; Grafstrom 
et al., 1979). 
In low dose, acetaminophen is metabolized by the liver where it is 
conjugated with sulfate and UDP-glucuronate. In overdosage, due to the 
low stores of UDPGA and sulfate, _the electrophilic metabolite of 
acetaminophen is conjugated to glutathione (Ameer and Greenblatt, 1977). 
When 70-80% of the glutathione is depleted, the toxic metabolite begins 
to covalently bind to tissue macromolecules and this depletion 
ultimately leads to cell death (Hinson et al., 1981; Jollow et al., 
1973). Inhibitors of cytochrome P-450, e.g., cobaltous chloride and 
piperonyl butoxide, reduce the amount of toxic metabolite formed and 
thus limit the hepatotoxic effects (Potter et al., 1973; Jollow et al., 
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1973). 
The hepatotoxic effects are also counteracted by N-acetylcysteine 
(Tredger et al., 1980), S-adenosyl-1-methionine (Stramentinoli et al., 
1979), sodium sulfate (Slattery and Levy, 1977) and a-mercaptopro-
pionylglycine (Labadarios et al., 1977). 
The present study was undertaken in order to ascertain a possible 
synergistic effect of ethanol (an inducer of microsomal oxidation) and 
acetaminophen on the extent of liver necrosis as measured by total liver 
glutathione (GSH) levels and plasma glutamic oxaloacetic transaminase 
(PGOT) and to discover the relationship between PGOT activity and 
hepatic GSH levels after exposure of the liver to the toxic metabolite. 
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REVIEW OF LITERATURE 
Acetaminophen 
Acetaminophen (N-acetyl-p-aminophenol) (Figure 1) is a commonly 
used antipyretic and analgesic agent found in over 200 drug 
formulations. It does not interfere with blood coagulation or cause 
gastrointestinal erosion as aspirin does and is preferred over aspirin 
in many cases (Die tz et al. , 1984; Black, 1980). 
NHCOCH 3 
OH 
Acetaminophen 
Figure 1. -=:h1:"1:~: 1l st r ucture of ac .::·,:n ~ :: - hen ( pHAA. ) 
At low dose it is a safe and effective drug but overdoses of the 
drug have been linked to hepatotoxicity. 
Acetaminophen was synthesized at Johns Hopkins University in 1877 
and first used clinically by von Mehring in 1893. In 1949, Axelrod and 
Brodie confirmed its therapeutic effects and its use became extensive 
(Ameer and Greenblatt, 1977; Jackson et al., 1984). 
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Pharmacologic Properties 
Unlike aspirin, acetaminophen does not have anti-inflammatory or 
antirheumatic properties (Ameer and Greenblatt, 1977; Black, 1980). 
Acetaminophen's mode of action may be due to its inhibition of 
prostaglandin synthetase, an inhibition which may be greater in the 
central nervous system (CNS) than in the peripheral tissues (Ameer and 
Greenblatt, 1977). 
Pharmacokinetics 
The absorption rate of acetaminophen is influenced by the rate of 
gastric emptying. Cohen et al. (1974) using isolated perfused rat liver 
found that the systemic circulation concentration of acetaminophen was 
only 34% of that by intravenous injection. Cohen suggested that the 
rate of gastric emptying could also influence the "first pass" effect of 
acetaminophen metabolism. A high rate of gastric emptying could give 
high concentrations of acetaminophen in the portal vein resulting in a 
lower hepatic extraction ratio leading to higher systemic concentra-
tions. A slow rate of gastric emptying would have a reverse effect. 
Acetaminophen ts a weak acid with a pKa of 9.5. In humans, it is 
rapidly absorbed from the gastrointestinal tract with peak plasma levels 
being reached in 30 to 60 minutes after oral ingestion. It is 
distributed uniformly throughout most body fluids (Volume of 
distribution Vd = 0.7 - 0.75 L/kg). It is also found bound to plasma 
proteins (25%) (Black, 1980). The absorption rate of acetaminophen ts 
faster from an alcohol solution (Ameer and Greenblatt, 1977). 
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Acetaminophen is metabolized by the liver and its metabolic 
products are excreted by the kidney. The plasma half-life of a normal 
dose of acetaminophen 1s 1-3 hours. The half life is prolonged 1n 
conditions such as overdosage or liver disease (Ameer and Greenblatt, 
1977; Jackson et al., 1984). Renal dsyfunction, however, has no effect 
upon the half-life of the drug. The hepatic extraction ratio is 
estimated to be between .245 -.265 which indicates a 25% first pass 
metabolism effect (Ameer and Greenblatt, 1977). The total metabolic 
clearance is from 5.15-5.57 ml/min·kg. The percentages of the 
metabolites appearing in the urine are as follows: glucuronide 
conjugates (UDPGA) (55-63%), sulfate conjugates (30-34%), cysteine and 
mercapturic acid conjugates (3-4%) and free acetaminophen (1-4%) 
(Jackson et al., 1984). 
Due to the limited hepatic stores of sulfate and UDPGA, more of the 
drug is oxidized to the cysteine and mercapturic acid conjugates with 
overdoses of the drug (Figures 2 and 3). These two conjugates are 
formed by the cytochrome P-450 mixed function oxidase system (Black, 
1980; Jackson et al., 1984; Ameer and Greenblatt, 1977). This system 1s 
also thought to form an intermediate arylating compound, N-acetyl-p-
benzoquinonemine. This compound is normally conjugated by glutathione 
(GSH), and the resulting mercapturic acids are excreted by the kidney 
(Jackson et al., 1984). In overdosage, the liver glutathione is 
deplet~d and the arylating metabolites attack liver cell macromolecules, 
resulting in cell death (Black, 1980). 
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Mechanism of Hepatotoxicity 
An intermediate arylating compound, postulated to be N-acetyl-p-
benzoquinoneimine is thought to be the causative agent of the fulminant 
centrilobular necrosis seen in cases of acetaminophen overdosage. This 
electrophilic metabolite is formed by the cytochrome P-450 mixed 
function oxidase system (Jackson et al., 1984). 
The severity of the necrosis produced is influenced by many 
factors. Inducers of drug metabolism such as phenobarbital and 3-
methylcholanthrene (3MC) which increase the cytochrome P-450 
concentration have been found to increase both the incidence and 
severity of necrosis. Inhibitors of drug metabolism such as piperonyl 
butoxide, SKF-525A and cobaltous chloride prevent or limit liver 
necrosis (Mitchell et al., 1973b; Jollow et al., 1973; Potter et al., 
1973). Piperonyl butoxide inhibits the oxidation of acetaminophen by 
combining with cytochrome P-450. Cobaltous chloride acts by blocking 
the synthesis of cytochrome P-450 at the ferrochelatase level (Mitchell 
et al., 1973a). 
The toxic metabolite becomes covalently bound to tissue 
macromolecules leading to cell death. In mice, pretreatment with 
compounds which increase the severity of necrosis also increase the 
amount of covalent binding observed and those pretreatments which 
decrease the amount of covalent binding (Jollow et al., 1973). 
Administration of subtoxic doses of acetaminophen produces insignificant 
binding in the liver. Covalent binding is prominent in the 
centrilobular cells, localized in the endoplasmic reticulum and Ln the 
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proteins of the cytoplasm (Jollow et al., 1973; Gillette et al., 1974). 
Binding is regulated by cytochrome P-450 which is in high 
concentrations in the centrilobular region. The amount of binding is 
dose-dependent and peak binding occurs one to two hours before necrosis 
can be observed. NADPH and o2 are required for binding to occur (Potter 
et al., 1973). 
Although the amount of covalent binding has been highly correlated 
with the extent of necrosis, compounds exist which do not decrease the 
amount of binding yet decrease the severity the extent of necrosis. Two 
of these sulphydryl compounds are N-acetylcysteine and a-mercaptopro-
pionglglycine (a-MPG) (Labadarios et al., 1977; Tredger et al., 1980; 
Gerber et al., 1977). a-MPG may act by either stabilizing the 
macromolecules against the effects of binding or by binding to the 
specific sties which are responsible for initiating cell necrosis 
(Labadarios et al., 1977). 
Diet Effects 
McLean and Day (1975) fed rats low protein diets and 25% yeast 
diets for at least one week before administration of acetaminophen alone 
or with inducers. The low protein diets were found to decrease the 
amount of cytochrome P-450/g liver, increase UDPGA transferase activity 
and to sharply decrease the liver glutathione levels. Phenobarbitone 
increased cytochrome P-450 levels but had no effect on glutathione 
levels. The rats fed the low protein diet were found to be highly 
sensitive to acetaminophen. This sensitivity was further increased by 
phenobarbitone elevation of cytochrome P-450. Cysteine and methionine 
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when injected with acetaminophen were found to reduce the lethality of 
acetaminophen hepatotoxicity. 
Stramentinoli et al. (1979) using mice injected both before and 
after acetaminophen administration with S-adenosyl-1-methionine observed 
a reduced acetaminophen-induced hepatotoxicity as evidenced by decreased 
necrosis and decreased GOT and GPT serum enzyme activities. Slattery 
and Levy (1977) found sodium sulfate injected intraperitoneally (i.p.) 
with acetaminophen reduced acetaminophen hepatotoxicity in mice. 
Miller and Jollow (1984) using hamsters, observed that L-ascorbic 
acid partially inhibited covalent binding of acetaminophen metabolites 
in isolated hepatocytes but did not influence covalent binding of the 
reactive metabolite in vivo or decrease the extent of hepatic necrosis. 
Pessayre et al. (1980) in studying effects of fasting and inducers 
alone and in combination on acetaminophen toxicity found that 
pretreatment with phenobarbital increased hepatic microsomal protein 
concentration, hepatic cytochrome P-450 levels, NADPH cytochrome c 
reductase activity, ethylmorphine N-demethylase activity and 
acetaminophen UDP-glucuronosyltransferase activity. Phenobarbital 
pretreatment had no effect on the amount of covalent binding in fed or 
fasted rats. Pretreatment with 3MC increased cytochrome P-448 and 
benzo[a]pyrene hydroxylase activity and the microsomal enzymes induced 
by phenobarbital except acetaminophen UDP-glucuronosyltransferase. 3MC 
increased the amount of covaient binding in both fed and fasted rats but 
the amount of binding was greater in the fasted group. 
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Fasting the rats for a period of 42 hours in the absence of 
inducers tended to increase microsomal protein concentration and reduced 
hepatic GSH concentration but only slightly decreased mixed function 
oxidase activities. 
Administration of a 500 mg/kg dose of acetaminophen further 
decreased the GSH concentration in the fasted rats as compared with the 
fed rats. Phenobarbital did not influence hepatic GSH concentration. 
Pretreatment with 3MC decreased hepatic GSH concentration in both the 
fed and fasted rats. 
It was concluded that inducers which increase microsomal enzyme 
activity and fasting which decreases hepatic GSH may have an additive 
effect on acetaminophen hepatotoxicity. 
Newman and Bargman (1979) in reporting a clinical case of 
acetaminophen in an anorexic adult male found no evidence of 
malnutrition potentiation of a hepatotoxic effect of acetaminophen. 
Although the prevention of liver damage may have been due solely to the 
administration of N-acetylcysteine, Newman and Bargman postulated that 
the dietary deficiencies present may have served to decrease the 
cytochrome P-450 activity relative to the GSH stores and thus prevented 
liver necrosis. It was concluded that if the postulate is in fact true, 
then malnourished patients/individuals may be more resistant t o 
acetaminophen induced liver necrosis. 
Effect of Age 
Hart and Timbrell (1979) in studying the effects of age on 
acetaminophen hepatotoxicity found that neonatal mice were less 
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susceptible than adult mice to the hepatotoxic effects of the reactive 
metabolite. They observed less GSH depletion, less covalent binding to 
tissue macromolecules, and less hepatic necrosis in the neonatal mice 
than in the adults. Neonate liver GSH reaches adult levels at about 10 
days of age (Lambert and Thorgeirsson, 1976; Wirth and Thorgeirsson, 
1978). Hart and Timbrell (1979) noted that hepatic cytochrome P-450 
reached adult levels at 16 days of age, the age at which susceptibility 
to acetaminophen toxicity is about the same as in adult mice. They 
concluded that the reduced susceptibility observed in the neonate mouse 
might be due to the lower cytochrome P-450 levels coupled with low but 
sufficient glutathione levels to bind the reactive metabolite. 
In human infants, the major urinary metabolite of acetaminophen is 
the sulfate conjugate, whereas in adults the major metabolite is the 
glucuronide conjugate. Thus, infants and children may have a reduced 
ability for glucuronide conjugation (Ameer and Greenblatt, 1977). 
Toxic Effects 
Hepatic 
Walker et al. (1980) using light and electron microscopy to examine 
the morphological changes in the liver of white mice after a 500 mg/kg 
dose of acetaminophen discovered the following: 
1. Numerous lipid droplets, particularly in the centrilobular 
region with only small amounts of glycogen visible in the 
midzonal and portal regions. The first visible histologic 
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changes occurred at 3/4 to 1 1/2 hours after administration of 
the dose. 
2. Vacuolization along sinusoidal margins of centrilobular cells 
occasionally conununicating with Disse's space. The cytoplasm 
appeared foamy due to dilation of both rough and smooth 
endoplasmic reticulum. 
3. Vesiculation of the rough endoplasm reticulum resulting in 
random dispersal of ribosomes, disaggregation of polyribosomes 
and possibly a decrease in protein synthesis were seen. The 
mitochondria appear swollen with detached cristae fragments 
and have bizarre forms. 
4. Three hours after dosage there was centrilobular congestion 
due to red blood cells (RBC) packed in the sinusoids, beneath 
sinusoidal lining cells and in some large cell vacuoles. 
There was also an increase seen in centrilobular fat. 
5. After three hours' loss of microvilli, gross disorganization 
of organelles, increase in platelet aggregates and obstruction 
of blood flow by narrowing of sinusoids are observed. 
Necrosis was maximum between 24 to 48 hours and regeneration 
evident at 48 to 72 hours. Inducers of drug metabolism were found to 
potentiate the extent of necrosis but not the onset of the histologic 
changes. 
Serum enzyme glutamic-oxaloacetic transaminase (SGOT), glutamic-
pyrovic transaminase (SGPT), sorbitol dehydrogenase (SSDH), and hepatic 
triglyceride are elevated after administration of an acute dose of .5 
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g/kg to 1.0 g/kg of acetaminophen in mice (Dixon et al., 1975; Buttar et 
al., 1976). Maximal hepatotoxic effects were observed 12-18 hours after 
administration of the dose. A close positive correlation was found 
between SGPT and SGOT levels and the extent of hepatic necrosis. Thus, 
the levels of these enzymes may be an indication of the severity of 
necrosis. In humans, the symptoms of acetaminophen overdosage progress 
gradually from nausea, malaise and vomiting within 12-24 hours after the 
overdosage to observable histologic changes occurring 4 to 6 days later. 
There is a sharp rise in SGOT and SGPT serum enzyme levels which returns 
to normal levels in 7 to 14 days. Mild acidosis, jaundice, abdominal 
pain, possible hepatic coma and death may also occur (Ameer and 
Greenblatt, 1977; Jackson et al., 1984). 
In diseased states 
Acetaminophen intake has been implicated in a number of patient 
case histories as either a cause of acute and chronic hepati c 
inflannnation and fibrosis or as an aggravator of underlying liver 
disease (Johnson and Tolman, 1977; Ware et al., 1978; Craig, 1980; 
Neuberger et al., 1980; Olsson, 1978; Bronkowsky et al., 1978). In many 
of these cases there were other underlying causes or confounding 
variables which may have been responsible for the actual disease. 
However, challenge tests with subtoxic doses of acetaminophen were found 
to elevate serum enzyme levels. 
Hypersensitivity reactions to acetaminophen have also been reported 
(Olsson, 1978). 
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Strubelt et al. 0979) reported finding an acetaminophen-induced 
protection against acetaminophen toxicity in rats. They concluded that 
this protection was due to a decrease in microsomal mixed function 
oxidase activity brought about by three days administration of a 1000 
mg/kg dose of acetaminophen. The hepatic GSH level was found to 
continually decrease over the three day period to 46% of the control 
level after which GSH concentration exceeded the control level by 85%. 
Renal 
Renal tubular necrosis has been reported after intake of large 
doses of acetaminophen. Tubular damage occurs primarily in the proximal 
tubules but the distal tubules are also affected. Renal damage is 
usually secondary to hepatic necrosis, although cases of renal damage in 
the absence of hepatic necrosis have been reported (Hinson, 1980; 
Jackson et al., 1984). 
Effect of Ethanol 
Acute and chronic ingestion of ethanol has been found to influence 
the following hepatic parameters: to decrease hepatic reduced gluta-
thione levels (Fernandez and Videla, 1981), i ncrease lipoperoxidation 
(Videla and Valenzuela, 1982; Videla et al., 1980), potentiate the 
toxicity of a variety of hepatotoxic agents (Strubelt et al . , 1978), 
alter the appearance of liver mitochondria (Kiessling and Pi lstrom, 
1966a, 1966b), and to induce drug metabolizing enzymes (Liu et al., 1975; 
Coon et al., 1984; Peterson et al., 1980). The depletion of GSH by 
ethanol is thought to take place via acetaldehyde (Vina et al., 1980b). 
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Ethanol induction of drug metabolism takes place via induction of 
the ethanol inducible isoenzyme 3a of cytochrome P-450 (Coon et al., 
1984). This induction has been demonstrated both in vivo and in vitro 
by a number of researchers in rats (Liu et al., 1975; Teschke et al., 
1979; Moldeus et al., 1980), in mice (Strubelt, 1984; Walker et al., 
1983; Banda and Quart, 1984) and in humans (Licht et al., 1980; McClain 
et al., 1980; Dietz et al., 1984). This research finding specifically 
relates to the potentiation of acetaminophen toxicity by ethanol. This 
potentiation is due to both its depletive effects on hepatic GSH (via 
acetaldehyde) and its induction of microsomal enzymes. Isoenzyme 3a ts 
also active toward amiline but not paranitroanisole. 
Glutathione 
Glutathione, y-glutamylcysteinylglycine, is found in almost all 
mannnalian cells. Its functions are related to its thiol group and its 
y- glutamyl moiety (Figure 4) (Bi nkley and Nakamura, 1948; Mei s ter, 1982 ; 
Stryer, 1981). 
Y-gl utamylcysteine 
synthetase 
Glutamate + cysteine + ATP Y-glutamylcysteine + ADP + P. 
I 
glutathione 
synthetase 
Y-Glutamylcysteine + glycine gfutathione + ADP + P. 
I 
Figure 4 . Glu ta t hi one b iosynthesis 
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Glutathione performs a variety of functions. It functions as an 
intracellular reductant, in the destruction of free radicals and 
peroxides, in the maintenance of red cell structure, keeping hemoglobin 
in the ferrous state, in amino acid transport and in the detoxification 
of xenobiotic compounds (Meister, 1982; Stryer, 1981; Meister, 1984; 
Sies et al., 1982; Levine, 1982; Mitchell et al., 1973b; Davis et al., 
1974; Prescott, 1982; Gagen and Klassen, 1980; Griffith and Meister, 
1979; Sekura and Meister, 1974). Glutathione S-transferases play an 
important role in detoxification (Grover, 1982; Ketterer et al., 1982; 
Jakoby, 1978; Uotila, 1973; Keen and Jakoby, 1978; Keen et al., 1976). 
Cellular glutathione levels are affected by diet (Tateishi et al., 
1982; Maruyama et al., 1968), fasting (Lauterberg and Mitchell, 1982; 
Jaeger et al., 1974) and diurnal cycles (Boor, 1979; Jaeger et al;, 
1973; Beck et al., 1958). 
Depletion of glutathione to less than 30% of normal can result in 
increased toxicity of electrophilic metabolites (Plummer et al., 1981). 
Depletion of GSH can result in increased toxicity of 1,1-dichloro-
ethylene (Jaeger et al., 1974), ethionine (Glaser and Mager, 1974), 
bromobenzene (Thor et al., 1979; Jollow et al., 1974) carbonyl compounds 
(Boyland and Chasseaud, 1970), acetaminophen (Davis et al., 1975; 
Benedetti et al., 1975; Vina et al., 1980a; Mitchell et al., 1973a) and 
a var iety of other chemical compounds. 
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MATERIALS AND METHODS 
Experiment 1 
Adult male Swiss Webster mice (Laboratory Supply Inc., 
Indianapolis, IN.) were acclimated to the laboratory environment for a 
period of one week in plastic cages under controlled light (12 hour, 
7a.m.-7p.m. light/dark cycle) and temperature (22°e) conditions. The 
mice were fed distilled water and laboratory chow (Teklad, Winfield, IA) 
ad lib. After week one, the mice were randomly assigned to three 
treatment groups: H20 + pHAA, 10% ethanol (EtOH), and 10% ethanol+pHAA 
which received either distilled water or a solution of 10% (V/V) 
ethanol. Food, fluid intake, and animal weights were measured weekly. 
After five weeks of treatment, the mice were fasted for a period of 24 
hours after which they were presented with either distilled water or 
acetaminophen (pHAA) in th~ drinking water 1000 mg/kg b.w. in each 3 ml 
of drinking water) ad lib. for a period of 2 hours. The mice were then 
killed by decapitation at various times after introduction of the 
acetaminophen. The liver was removed and frozen quickly in liquid 
nitrogen and stored at -80°e for analysis of total glutathione 
concentration. Blood was collected in heparinized tubes, centrifuged 
and the plasma immediately analyzed for plasma oxaloacetic transaminase, 
(PGOT) activity or was stored at -80°e until the next day. 
Experiment 2 
Adult male Swiss Webster mice were exposed to the same conditions 
as in Experiment 1 excepting the one week acclimation period. All mice 
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received 10% (V/V) ethanol in the drinking water. After five weeks, the 
mice were fasted for a period of 24 hours after which they were given 
either 10% ethanol or pHAA (1000 mg/kg b.w. in each 3 ml of drinking 
water) ad lib. The animals were sacrificed and tissues collected as 
noted in experiment one. 
Experiment 3 
Adult male Swiss Webster mice were exposed to the same conditions 
as in Experiment 1 excepting the one week acclimation period. The mice 
were divided into three groups receiving either distilled water or a 10% 
(V/V) ethanol solution. 
After four weeks, the mice were fasted for 24 hours and injected 
intraperitoneally (i.p.) with either acetaminophen (750 mg/kg) dissolved 
in propylene glycol (60 mg/ml) or an equivalent volume of propylene 
glycol and sacrificed at various times after injection as in experiment 
one. 
Assays 
Total glutathione was determined according to Jollow et al. (1973) 
by the method of Ellman (1959). PGOT was determined by using a reagent 
kit (Sigma Chemical Company, St. Louis, Mo.). Acetaminophen used was 
obtained from Sigma Chemical Company. 
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RESULTS AND DISCUSSION 
Effects on Glutathione Levels 
In Experiment 1, highly significant time, treatment and treatment x 
time interactions were observed (Tables 1 and 2; Figure 5). All 
treatments were significantly different from one another, however, only 
the 18 hr results were significantly different from those at the 4, 6, 
and 10 hour times. 
There was a trend observed for a negative correlation for GSH and 
PGOT levels and treatment, but it was not significant. This same trend 
was observed for the PGOT and GSH levels at the various times, but 
again, it was not significant (Tables 3 and 4). 
In Experiment 2, significant treatment differences were found, but 
there were no significant time or treatment x time effects (Tables 5 and 
6; Figure 5). No significant correlations between GSH and PGOT levels 
were observed (Tables 7 and 8). 
In Experiment 3, highly significant time and treatment effects were 
observed (Table 9; Figure 7). Only the 10% ethanol + 0 group was 
responsible for the difference. The 10% ethanol + pHAA and H2o + pHAA 
groups were not significantly different (Table 11). 
A negative correlation between GSH and PGOT levels was observed for 
all treatments, however, only the H20 + pHAA and 10% ethanol + 0 groups 
had a significant negative correlation between GSH and PGOT levels. All 
times were negatively correlated for GSH and PGOT levels, but only the 
0.5 hr and 1.0 hr times were significantly correlated (Tables 11 and 12). 
In Experiment 1, the significance at 18 hr was probably due to the 
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Table 1. Exp. 1. Analysis of variance of glutathione and plasma oxalo-
acetic transaminase 
GSH PGOT 
Source F Value PR > F F Value 
TRT 46.97 .0001 19.25 
TIME 30.83 .0001 5.38 
TRT*TIME 6.36 .0043 2.18 
Table 2. Exp. 1. Average glutathione and plasma oxaloacetic 
transaminase values 
GSH (umoles/g liver) PGOT (U/L) 
TRTl TIME (hr) TRT 1 TIME 
1. 3. 92a2 4. 2.74a2 1. 36oo.a2 4. 
2. 4.87b 6. 3.58b 2. 331.zb 6. 
3. 2.zzc 10. 3.13a,b,c 3. 3285.7a 10. 
18. 5.38d 18. 
PR > F 
.0006 
.0214 
.1409 
(hr) 
1508.8a2 
1543.0a 
1851. 9a 
3892.4b 
1Treatment one = H20 + pHAA, treatment two = 10% EtOH onl y , 
treatment three = 10% EtOH + pHAA. 
2Means with same letter are not significantly different at P < .OS. 
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Table 3. Exp. 1. Glutathione: Plasma glutamic oxaloacetic 
transaminase correlation coefficients (r) 
TRT TIME (hr) 
1. -.634 4. -.634 10. -.919 
(.250)a (.251) (. 081) 
2. -.603 6. -.553 18. .365 
( .114) (.255) (.477) 
3. .6314 
(.179) 
apR > F appears under correlation coefficient. 
effects of both diurnal variation (Jaeger et al., 1973) and the increase 
in glutathione synthesis observed after depletion. In this rebound 
period, GSH levels can increase up to twice that of control values 
(Plummer et al., 1981). 
Fasting also lowers hepatic GSH levels by about 30% (Lauterberg and 
Mitchell, 1982. This decrease in GSH levels occurs during the first 12 
hours, after which the levels remain constant. The mice used in this 
series of experiments were fasted in order to increase the absorption of 
acetaminophen. The mice were sacrificed between the hours of 10 AM and 
2 PM, the time that the level of hepatic GSH is at its zenith in the 
diurnal cycle (Jaeger et al., 1973). At least partly due to its 
glutathione lowering effect, fasting also affects the toxicity of 
various xenobiotics (Pessayre et al., 1980; Lauterberg and Mitchell, 
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1982; Plummer et al., 1981). In Experiments 2 and 3, the significant 
treatment effects were due to the effect of the acetaminophen alone. No 
induction of microsomal oxidation by ethanol seems to have occurred 
although such induction has been reported widely in the literature 
(Banda and Quart, 1984; Moldeus et al., 1980; McClain et al., 1980; Coon 
et al., 1984; Teschke et al., 1979; Peterson et al., 1980; Licht et al., 
1980; Walker et al., 1983; Charles River Breeding Laboratories, 1976; 
Strubelt et al., 1978). Depletion of GSH due to the effect of ethanol 
itself has also been reported (Fernandez and Videla, 1981). This is 
thought to be due to acetaldehyde, a metabolite of ethanol, because 
inhibition of alcohol dehydrogenase eliminates the observed depletion. 
Table 4. Exp. 2. Analysis of variance of glutathione and plasma oxalo-
acetic transaminase 
GSH PGOT 
Source F Value PR > F F Value PR > F 
T~ 7.55 .0125 91.77 .0001 
TIME 1.48 .2525 .85 .4441 
TRT*TIME 
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Table 5. Exp. 2. Average glutathione and plasma oxaloacetic 
transaminase values 
GSH (umoles/g liver) PGOT (U/L) 
TRTl TIME (hr) TRTl TIME (hr) 
1. 6.52a2 2.0 6.39a2 1. 437.6a2 2.0 495.6a2 
2. 4.6lb 2.5 6 . 04a 2. 1052.9b 2.5 663.0b 
3.0 5.32a 3.0 424.9a 
1Treatment one = 10% EtOH only, treatment two = 10% EtOH + pHAA. 
2Means with same letter are not significantly different at P < .05. 
Table 6. Exp. 2. Glutathione : Plasma oxaloacetic transaminase 
correlation coefficients (r) 
TRT TIME (hr) 
1. .049 2.0 .635 3.0 .884 
(.846)a (.175) (.310) 
2. -.482 2.5 -.489 
( . 333) ( . 064) 
aPR > F appears under correlation coefficient (r). 
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Effect on PGOT 
In Experiment 1, highly significant treatment effects and 
significant time effects were observed (Table 1). The treatment 
significance was due to the 10% ethanol + 0 group, the pHAA + H2o and 
pHAA + 10% ethanol groups were not significantly different (Table 2; 
Figure 6). Only the 18 hr time was significantly different from all 
other times. This was due to the elevation of PGOT after administration 
of pHAA, which elevation is maximal at 24 hr (Dixon et al., 1975). 
In Experiment 2, there was a highly significant treatment effect 
but no significant time effect (Table 5; Figure 8). Again, as in 
Experiment 1, the treatment significance was due to the presence of 
acetaminophen since both groups were treated with 10% ethanol in this 
experiment (Table 6). 
In Experiment 3, highly significant time and treatment effects were 
observed (Table 9; Figure 7). The time effect observed in this 
experiment but not in Experiment 2 was probably due to the method of 
acetaminophen administration; ad libidium in drinking water in 
Experiment 2 as opposed to intraperitoneal (i.p.) injection in 
Experiment 3. The i.p. injection allowed smaller time interval 
measurements after administration and also a constant dosage per animal. 
The treatment effect observed, as in the two previous experiments was 
due to the 10% ethanol+ 0 group (Table 10). 
The (0.5 hr, 0 hr) and (0.5 hr, 1.0 hr) times were not 
significantly different. The 2 hr time was significantly different from 
all others (Table 10). 
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Table 7. Exp. 3. Analysis of variance of glutathione and plasma oxalo-
acetic transaminase 
GSH PGOT 
Source df F Value PR ) F df F Value PR ) F 
TRT 2 17.60 .0001 2 11.03 .0002 
TIME 3 13.53 .0001 3 11. 23 .0001 
TRT*TIME 6 1.97 .0981 6 1. 90 .1131 
Table 8. Exp. 3. Average glutathione and plasma glutamic oxaloacetic 
transaminase values 
GSH (umoles/g liver) PGOT (U/L) 
TRTl TIME (hr) TRTl TIME (hr) 
1. 3.67a2 0 7.26a 1. 1838.8a 0 652.3a 
2. 6.74b o.s 4.43b 2. 830.la 0.5 1392.8a,b 
3. 3.64a 1. 0 2. 86C 3. 2206.4a 1.0 1603.3b,c 
2.0 4.33b,d 2.0 2644.8 d 
1Treatment one = H20 + pHAA, treatment two 
treatment three = 10% EtOH + pHAA. 
10% EtOH only, 
2Means with same letter are not significantly different at P < .05. 
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Table 9. Exp. 3. Glutathione: Plasma glutamic oxaloacetic 
transaminase correlation coefficients (r) 
TRT TIME (hr) 
1. -.662 0 -.014 1.0 -.651 
(.009)a (. 968) (. 030) 
2. -.174 0.5 -.957 2.0 - .427 
(.552) (.0002) (.166) 
3. -.626 
(.017) 
apR > F appears under correlation coefficient (r). 
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A negative correlation between GSH and PGOT levels was expected in 
the above experiments. Serum transaminase levels are thought to give a 
reliable index of the extent of cellular damage (Dixon et al., 1975; 
Buttar et al., 1976). Because the electrophilic metabolite of 
acetaminophen would tend to decrease glutathione levels acutely and 
thus increase the extent of hepatic necrosis over time, serum enzyme 
activity was postulated to increase over time and thus be negatively 
correlated to the level of hepatic glutathione. 
Negative correlations were observed for both treatment and time in 
Experiments 1 and 3, but only for one time period in Experiment 2. 
Although negative correlations were observed in Experiment 1, they were 
not significant. Only in Experiment 2 were significant correlations 
observed. 
Effect of Diet and Fasting 
The ethanol treated mice ingested significantly less fluid than 
their water treated counterparts (Figures 9-12). This may be due to an 
aversion to ethanol or to its caloric content. In Experiment 1, food 
consumption was approximately the same for both groups, but in 
Experiment 3 food consumption was significantly different (Figures 11 and 
12). This may have been due to the one-week acclimatization period used 
in Experiment 1. Fasted animals weighed an average of 4.02 g less than 
non-fasted ones, a statistically significant difference (Table 13). 
I 
Liver weight for the ethanol treated group was significantly higher than 
the water treated group in Experiment 3. 
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Table 10. Exp. 1. Total hepatic glutathione content and plasma 
glutamic-oxaloacetic transaminase activity after ad lib. 
acetaminophen dose 1000 mg/kg/3 mla 
GSH 
Treatment Time (hr) after umoles/g liverb PGOT (U/L)b 
condition administration wet weight 
1. H20 + pHAA 4 2.63 + .69 (2) 275.3 + 927. 9 
6 4.16 + .77 (2) 1700.5 + 2234.3 
10 2.98 + .38 (2) 2709 
18 5.92 + .54 (2) 6793.7 + 987.7 
2. 10% EtOH 4 4.67 + .24 (2) 147.6 + 29.9 
6 5.50 + .71 (2) 166.7 + 47.1 
10 4.04 + .57 (2) 761. 9 + 119.7 
18 5.27 + .18 (2) 248. 7 + 37.4 
3. 10% EtOH+pHAA 4 .92 + .65 (2) 1746 
6 1.07 + .47 (2) 2761.9 + 2110.1 
10 1.64 + (1) 3174.6 
18 4.95 + .25 (2) 4634.9 + 269.4 
(2) 
(2) 
(1) 
(2) 
(2) 
(2) 
(2) 
(2) 
(1) 
(2) 
(1) 
(2) 
aAvg. dose for treatment one= 1.57 + .29 ml (521.7 mg/kg), avg. 
dose for treatment two = 3.00 ml 10% EtOH; avg. dose for treatment three 
2.32 +ml (771.7 mg/kg). 
bEach value is the mean + the standard error of the mean of n 
observations. Numbers in parentheses are the number of observations. 
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Table 11. Exp. 2. Total hepatic glutathione content and plasma 
glutamic oxaloacetic transaminase activity after ad lib. 
acetaminophen dose 1000 mg/kg/3 mla 
GSH 
Treatment Time (hr) after umoles/g liverb PGOT (U/L)b 
condition administration wet weight 
1. 10% EtOH 2.0 6.39 + .88 ( 6) 495.6 + 89.0 
2.5 7. 00 + 1. 65 (9) 403.1 + 113.9 
3.0 5.33 + 1.02 (3) 424.9 + 149.1 
2. 10% EtOH+pHAA 2.5 4.61 + 1. 77 (6) 1052.9 + 191.5 
- -
( 6) 
(9) 
(3) 
(6) 
aAvg. dose for treatment one 1/58 + .97 ml 10% ethanol, avg. dose 
for treatment two= 1.25 + .35 ml (416.7 ;g/kg). 
bEach value is the mean + the standard error of the mean of n 
observations. Numbers in parentheses are the number of observations. 
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Table 12. Exp. 3. Total hepatic glutathione content and plasma 
glutamic-oxaloacetic transaminase activity after ad lib. 
acetaminophen dose of 7SO mg/kg body weight 
GSH 
Treatment Time (hr) after umoles/g livera PGOT (U/L)a 
condition administration wet weight 
1. H20 + pHAA 0 7.07 + .32 (3) 892.S + 199.2 
o.s 3.86 + 1.13 (4) 2S20.S + 1S68.8 
1.0 2.93 + .84 (4) 1627.4 + 307.7 
2.0 1.67 + .SS (4) 2248.7 + 347. 
2. 10% EtOH 0 7.79 + 2.90 (4) 26S.8 + 76.7 
o.s S.43 + • 37 (3) SlS.9 + 138.1 
1.0 7.89 + 3.49 (4) 768.1 + 41.S 
2.0 s.s2 + .67 (4) 17SS.l + llSl.9 
3. 10% EtOH+pHM 0 6. 68 + 2.13 ( 4) 8S8.6 + 202.0 
o.s 3.86 + .76 (3) 14SS.O + 37.4 
1.0 2.48 + 1.10 ( 4) 220S.6 + 6Sl.S 
2.0 1. 39 + .39 (4) 3930.6 + 1803.0 
(3) 
(3) 
( 4) 
(4) 
( 4) 
(4) 
(3) 
(4) 
(4) 
(2) 
(4) 
(4) 
aEach value is the mean + standard deviation of the mean of n 
observations. Numbers in parentheses are the number of observations. 
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Table 13. Effect of diet and fasting 
Treatment 
Exp. l_ 
EtOH 
H20 
Exp. l 
Et OH 
Exp. l 
Et OH 
H20 
Nonf asted 
Fasted 
Avg. wt. gain 
3.69 + 3.48 
8.13 + 2.64 
23.52 + 2.96 
10.55 + 2.54 
10.00 + 2.41 
Avg. wt at termination 
33.25 + 5.27 
29.88 + 1.89 
34.51 + 3.28 
32.42 + 2.60 
31.67 + 3.67 
32.27 + 2.79 
** 28.07 + 2.75 
*Means significantly different at P < .01. 
** Means significantly different at P < .001. 
Liver wt. 
1.60 + .38 
1.40 + .27 
1.45 + .26 
1. 40 + .13* 
1.28 + .15 
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SUMMARY 
The results from this study confirm an inverse relationship between 
liver GSH levels and PGOT activity after administration of an acute high 
dose of acetaminophen. 
No evidence for increased susceptibility to acetaminophen-induced 
hepatic necrosis by ethanol was observed. Ethanol treated animals 
tended to ingest less fluid and consume less solid food than water 
treated animals. However, body weights at termination of the 
experiments and average weight gain were not significantly different and 
thus are not thought to have influenced data. 
Onset of changes in the levels of GSH and PGOT as influenced by 
acetaminophen dosage was noted to occur between 0 minutes and 30 minutes 
of dosing. 
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